YTHDF1 and cancer: Here, we report both clinical and preclinical findings: YTHDF1 elevation in DCs after RT was associated with unfavorable outcomes in patients, and IR-induced YTHDF1 in DCs impaired the antitumor immunity elicited by IR in multiple murine cancer models.